Michael Chan

3.9k total citations · 1 hit paper
37 papers, 1.2k citations indexed

About

Michael Chan is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Transplantation. According to data from OpenAlex, Michael Chan has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 16 papers in Cardiology and Cardiovascular Medicine and 9 papers in Transplantation. Recurrent topics in Michael Chan's work include Transplantation: Methods and Outcomes (16 papers), Renal Transplantation Outcomes and Treatments (9 papers) and Heart Failure Treatment and Management (7 papers). Michael Chan is often cited by papers focused on Transplantation: Methods and Outcomes (16 papers), Renal Transplantation Outcomes and Treatments (9 papers) and Heart Failure Treatment and Management (7 papers). Michael Chan collaborates with scholars based in Canada, United States and Singapore. Michael Chan's co-authors include Akshay S. Desai, Michael M. Givertz, Anita Deswal, Carolyn L. Lekavich, Sharon A. Hunt, David Aguilar, Ileana L. Piña, Shannon M. Dunlay, Rozalina G. McCoy and Robert J. Mentz and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Spine.

In The Last Decade

Michael Chan

36 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update

2019 401 citations Shannon M. Dunlay, Michael M. Givertz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Chan Canada	16	589	430	325	146	142	37	1.2k
Jung Nam An South Korea	21	255 0.4×	229 0.5×	120 0.4×	79 0.5×	88 0.6×	83	1.4k
Karl J. Krobot United States	15	250 0.4×	381 0.9×	317 1.0×	80 0.5×	57 0.4×	32	1.2k
Dwight Stapleton United States	21	677 1.1×	806 1.9×	55 0.2×	244 1.7×	88 0.6×	52	1.5k
Sergio V. Perrone Argentina	18	1.1k 1.8×	285 0.7×	285 0.9×	50 0.3×	35 0.2×	63	1.5k
Charalampos Loutradis Greece	22	679 1.2×	437 1.0×	267 0.8×	32 0.2×	79 0.6×	89	1.4k
Iris Kingma Canada	21	685 1.2×	244 0.6×	106 0.3×	58 0.4×	227 1.6×	39	1.4k
Mads Hornum Denmark	22	166 0.3×	564 1.3×	673 2.1×	247 1.7×	199 1.4×	100	1.6k
Stephanie DeLoach United States	12	658 1.1×	261 0.6×	155 0.5×	24 0.2×	45 0.3×	21	1.3k
Elena Ratto Italy	22	843 1.4×	197 0.5×	269 0.8×	48 0.3×	63 0.4×	53	1.5k
Takahiro Shinzato Japan	17	141 0.2×	287 0.7×	142 0.4×	45 0.3×	88 0.6×	73	1.1k

Countries citing papers authored by Michael Chan

Since Specialization

Citations

This map shows the geographic impact of Michael Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Chan more than expected).

Fields of papers citing papers by Michael Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Chan. The network helps show where Michael Chan may publish in the future.

Co-authorship network of co-authors of Michael Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Chan. A scholar is included among the top collaborators of Michael Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Chan. Michael Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chan, Michael, et al.. (2023). Practical Pharmacological Treatment of Heart Failure: Does Ejection Fraction Matter Anymore?. Journal of Cardiovascular Development and Disease. 10(3). 114–114. 1 indexed citations

Chan, Michael, et al.. (2023). SGLT2 Inhibitors: The Next Blockbuster Multifaceted Drug?. Medicina. 59(2). 388–388. 16 indexed citations

Chan, Michael & Anselm Wong. (2020). Management and monitoring of large enoxaparin overdose treated with protamine. Emergency Medicine Australasia. 32(4). 712–713. 1 indexed citations

Dunlay, Shannon M., Michael M. Givertz, David Aguilar, et al.. (2019). Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America. Journal of Cardiac Failure. 25(8). 584–619. 89 indexed citations

Vest, Amanda R., Michael Chan, Anita Deswal, et al.. (2019). Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee. Journal of Cardiac Failure. 25(5). 380–400. 149 indexed citations

Alghamdi, Faisal & Michael Chan. (2017). Management of heart failure in the elderly. Current Opinion in Cardiology. 32(2). 217–223. 12 indexed citations

Ezekowitz, Justin A., Robert C. Welsh, Neil Brass, et al.. (2014). Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 (PROACT-3). Canadian Journal of Cardiology. 30(10). 1208–1215. 14 indexed citations

Chan, Michael & Ross T. Tsuyuki. (2013). Heart failure in the elderly. Current Opinion in Cardiology. 28(2). 234–241. 5 indexed citations

Clark, Alexander M., et al.. (2010). Healthy diet in Canadians of low socioeconomic status with coronary heart disease: Not just a matter of knowledge and choice. Heart & Lung. 40(2). 156–163. 21 indexed citations

10.

Haddad, Haissam, Debra Isaac, Jean‐François Légaré, et al.. (2009). Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary. Canadian Journal of Cardiology. 25(4). 197–205. 24 indexed citations

11.

Chan, Michael & Glen J. Pearson. (2007). New advances in antirejection therapy. Current Opinion in Cardiology. 22(2). 117–122. 11 indexed citations

12.

White, Michel, Haissam Haddad, Marie-Hélène Leblanc, et al.. (2005). Conversion From Cyclosporine Microemulsion to Tacrolimus-Based Immunoprophylaxis Improves Cholesterol Profile in Heart Transplant Recipients With Treated but Persistent Dyslipidemia: The Canadian Multicentre Randomized Trial of Tacrolimus vs Cyclosporine Microemulsion. The Journal of Heart and Lung Transplantation. 24(7). 798–809. 29 indexed citations

13.

Chan, Michael, et al.. (2005). Use of Echocardiography to Assess Function of hDAF-Transgenic Pig Cardiac Xenografts. Transplantation Proceedings. 37(4). 1923–1925. 4 indexed citations

14.

Shiba, Nobuyuki, Michael Chan, Bernard W.K. Kwok, et al.. (2004). Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience. The Journal of Heart and Lung Transplantation. 23(2). 155–164. 55 indexed citations

15.

Cantin, Bernard, Bernard W.K. Kwok, Nobuyuki Shiba, et al.. (2003). Post-operative conversion from cyclosporine to tacrolimus in heart transplantation: a single-center experience. The Journal of Heart and Lung Transplantation. 22(7). 723–730. 12 indexed citations

16.

Cantin, Bernard, Bernard W.K. Kwok, Michael Chan, et al.. (2003). The impact of brain death on survival after heart transplantation: time is of the essence. Transplantation. 76(9). 1275–1279. 36 indexed citations

17.

Shiba, Nobuyuki, Michael Chan, Hannah A. Valantine, et al.. (2003). Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era. The Journal of Heart and Lung Transplantation. 22(10). 1098–1106. 18 indexed citations

18.

Chan, Michael, Bernard W.K. Kwok, Nobuyuki Shiba, et al.. (2002). Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection. Transplantation Proceedings. 34(5). 1850–1852. 7 indexed citations

19.

Chan, Michael, Nadia Giannetti, Tomoko Kato, et al.. (2001). Severe tricuspid regurgitation after heart transplantation. The Journal of Heart and Lung Transplantation. 20(7). 709–717. 80 indexed citations

20.

Kato, Tadafumi, Y Namii, Takaaki Kobayashi, et al.. (2000). Early introduction of HMG-CoA reductase inhibitors could prevent the incidence of transplant coronary artery disease. Transplantation Proceedings. 32(2). 331–333. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact